siRNA, Anti-Human ACTN1, LNA(CAT#: SIRGT04049WQ-LNA)

The product SIRGT04049WQ-LNA is a type of small interfering RNA (siRNA) that targets ACTN1 gene and regulates the expression of gene. The siRNA interferes with the expression of ACTN1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001102.3; NM_001130004.1; NM_001130005.1
Alternative Names BDPLT15
Related Diseases Bleeding Disorder, Autosomal Dominant Macrothrombocytopenia
Purification HPLC
Target Gene
Gene ID 87
Uniprot ID P12814

Related Products